Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
Razieh Parizad, Researcher at Tabriz University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Exploration of Neuroprotective Therapy, adding:
“Excited to share that our systematic review, ‘Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety’, has been published in Exploration of Neuroprotective Therapy.
This systematic review evaluates the efficacy and safety of FXI inhibitors compared to DOACs for stroke prevention in atrial fibrillation.
Key findings include a significant reduction in major bleeding with FXI inhibitors, although DOACs were more effective in preventing stroke or systemic embolism.
I am grateful to express my sincere gratitude to Dr. Bata for his invaluable mentorship, guidance, and support throughout this work.
I am also grateful to my co-authors for their collaboration and contributions.”
Title: Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety
Authors: Razieh Parizad, Juniali Hatwal, Haleh Bodagh, Akash Batta, Bishav Mohan
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios AndreadisÖ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI